Members |
targetComponentId |
Tiaprofenic acid 300mg m/r capsule |
Product containing precisely tiaprofenic acid 300 milligram/1 each prolonged-release oral capsule (clinical drug) |
Tibetan pin-tailed sandgrouse |
Pterocles alchata (organism) |
Tibetan pin-tailed sandgrouse |
Syrrhaptes tibetanus (organism) |
Tibia tendon transfer (& Hauser) |
Tibial tendon transfer |
Tibia vara |
Blount disease |
Tibia vara |
Varus deformity of tibia (disorder) |
Tibial augmentation method |
Augmentation of tibia |
Tibial nerve and its branches |
Entire tibial nerve |
Tibial nerve and its branches |
Structure of tibial nerve |
Tibial nerve lesion |
Tibial nerve palsy |
Tibial nerve lesion |
Tibial nerve lesion (disorder) |
Tibial neuropathy |
Tibial nerve palsy |
Tibial neuropathy |
Tibial neuropathy (disorder) |
Tibial neuropathy |
Tibial nerve lesion (disorder) |
Tibial neuropathy |
Tibial neuropathy (disorder) |
Tibial neuropathy |
Tibial nerve palsy |
Tibial osteotomy (& upper) |
Osteotomy of proximal tibia |
Tibial osteotomy |
Osteotomy of proximal tibia |
Tibial osteotomy (& upper) |
Osteotomy of tibia |
Tibial osteotomy |
Osteotomy of tibia |
Tibialis anticus tendinitis |
Tibialis anterior tendinitis |
Tibialis posterior rupture |
Rupture of tibialis posterior tendon (disorder) |
Tibiofibular ligament (& distal) |
Structure of ligament of distal tibiofibular joint |
Tic |
Tic (finding) |
Tic |
Tic disorder |
Tic |
Tic (finding) |
Tic |
Tic disorder |
Tic |
Tic disorder |
Tic |
Tic (finding) |
Tic disorder |
Tic (finding) |
Tic disorder |
Tic disorder |
Ticarcillin and clavulanic acid adverse reaction |
Adverse reaction to clavulanic acid and/or ticarcillin |
Ticarcillin disodium with clavulanate potassium |
Clavulanate potassium (substance) |
Ticarcillin disodium with clavulanate potassium |
Ticarcillin disodium |
Tick bite without infection |
Bite of tick (event) |
Tick bite without infection |
Tick bite |
Tick paralysis causing toxic effect |
Tick paralysis |
Tick-borne bunyavirus encephalitis |
Nairoviral encephalitis (disorder) |
Tick-borne bunyavirus fever |
Disease caused by Nairovirus (disorder) |
Tick-borne bunyavirus fever |
Tick-borne orthobunyavirus fever |
Tick-borne encephalitis vaccine |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne encephalitis vaccine |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne encephalitis vaccine injection solution prefilled syringe |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne flavivirus encephalitis |
Encephalitis due to tick-borne encephalitis virus subgroup |
Tick-borne flavivirus encephalitis |
Tick-borne encephalitis |
Tick-borne viral encephalitis |
Tick-borne encephalitis |
Tick-borne viral encephalitis |
Viral encephalitis transmitted by tick |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Ability to sense tickle (observable entity) |
Tidal river |
Tidal river water (substance) |
Tidal river |
Tidal river (environment) |
Tile &/or slab caster |
Tile caster |
Tile &/or slab caster |
Slab caster |
Tile &/or slab caster |
Tile/slab caster |
Tile &/or slab caster |
Tile/slab caster |
Tile &/or slab caster |
Slab caster |
Tiler |
Floor/wall tiler (occupation) |
Tiler |
Tiler |
Tiler |
Tiler |
Tiler |
Floor/wall tiler (occupation) |
Time duration (property) (qualifier value) |
Time (attribute) |
Time duration (property) (qualifier value) |
Time (property) (qualifier value) |
Timed six meter walk |
Timed six meter walk time (observable entity) |
Timed six meter walk |
Timed six metre walk technique |
Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
Timolol 0.25% liquid eye gel |
Timolol (as timolol maleate) 2.5 mg/mL eye gel |
Timolol 0.5% eye drops preservative free |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol 0.5% liquid eye gel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye gel (clinical drug) |
Timothy grass |
Phleum pratense (organism) |
Timothy grass |
Phleum |
Timothy grass pollen allergen |
Timothy grass pollen (substance) |
Tinamou |
Family Tinamidae (organism) |
Tinamou |
Order Tinamiformes (organism) |
Tinea barbae |
Deep bacterial folliculitis (disorder) |
Tinea barbae |
Pseudofolliculitis barbae (disorder) |
Tinea barbae |
Tinea barbae (disorder) |
Tinea barbae |
Bacterial folliculitis (disorder) |
Tinea cruris |
Tinea of perianal region (disorder) |
Tinea cruris |
Tinea cruris (disorder) |
Tinea nigra |
Infection by Cladosporium werneckii |
Tinea nigra |
Microsporosis nigra |
Tinea nigra |
Tinea nigra |
Tinea pedis caused by combined/concurrent infection |
Tinea pedis |
Tinea profunda |
Tinea profunda |
Tinea profunda |
Deep seated dermatophytosis |
Tinea unguium |
Onychomycosis (disorder) |
Tinea unguium |
Onychomycosis due to dermatophyte |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
Tinzaparin sodium 10,000iu/mL injection solution 0.25mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 0.35mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 0.45mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 2mL vial |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.5mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.7mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.9mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 2mL vial |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tioconazole 28% solution |
Tioconazole 283 mg/mL cutaneous solution |
Tissierella species |
Tissierella |
Tissue cell sample |
Cytologic material |